In addition, oligodendrogliomas have the 1p/19q codeletion and TERT promoter mutations phenotype, while TP53 and ATRX mutations predominantly occur in grade II/III astrocytoma and secondary GBM. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).